Literature DB >> 4389201

Effects of opiates and opiate antagonists on the Straub tail reaction in mice.

M D Aceto, D B McKean, J Pearl.   

Abstract

1. Subcutaneous injections of opiates produced the Straub tail reaction in mice. The potencies of the opiates in mice were consistent with previous estimates of the analgesic potencies in animals and in man.2. The potencies of sixteen antagonists in counteracting the reaction were consistent with those previously obtained with the rat tail-flick test.3. The (-) isomers of four benzomorphan derivatives were much more potent in counteracting the reaction than their (+) isomers and about twice as potent as their racemates. The activity of the isomers seemed to follow Pfeiffer's rule: the lower the effective dose of a drug, the greater the difference in the pharmacological effects of the optical isomers. One of the trans isomers acted like an opiate, while its cis isomer acted like an antagonist.4. Naloxone and nalorphine fulfilled conventional criteria for competitive antagonism, whereas atropine and the (-) and the (+) isomers of pentazocine and of cyclazocine did not do so.5. The Straub tail test seems to be useful for studying structure-activity relations among opiates and opiate antagonists.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4389201      PMCID: PMC1703383          DOI: 10.1111/j.1476-5381.1969.tb09500.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  17 in total

1.  STUDIES ON THE HUMAN ADDICTION LIABILITY OF 2'-HYDROXY-5-9-DIMETHYL-2-(3,3-DIMETHYLALLYL)-6,7-BENZOMORPHAN (WIN 20,228): A WEAK NARCOTIC ANTAGONIST.

Authors:  H F FRASER; D E ROSENBERG
Journal:  J Pharmacol Exp Ther       Date:  1964-02       Impact factor: 4.030

Review 2.  THE CLINICAL EVALUATION OF MORPHINE AND ITS SUBSTITUTES AS ANALGESICS.

Authors:  L LASAGNA
Journal:  Pharmacol Rev       Date:  1964-03       Impact factor: 25.468

3.  USE OF WRITHING TEST FOR EVALUATING ANALGESIC ACTIVITY OF NARCOTIC ANTAGONISTS.

Authors:  H BLUMBERG; P S WOLF; H B DAYTON
Journal:  Proc Soc Exp Biol Med       Date:  1965-03

4.  Antagonisms and antagonists.

Authors:  S LOEWE
Journal:  Pharmacol Rev       Date:  1957-06       Impact factor: 25.468

5.  A method for evaluating both non-narcotic and narcotic analgesics.

Authors:  E SIEGMUND; R CADMUS; G LU
Journal:  Proc Soc Exp Biol Med       Date:  1957 Aug-Sep

6.  Synthetic substances with morphine-like effect; relationship between analgesic action and addiction liability, with a discussion of the chemical structure of addiction-producing substances.

Authors:  N B EDDY; H HALBACH; O J BRAENDEN
Journal:  Bull World Health Organ       Date:  1956       Impact factor: 9.408

7.  Prevention of writhing and other effects of narcotics and narcotic antagonists in mice.

Authors:  J Pearl; M D Aceto; L S Harris
Journal:  J Pharmacol Exp Ther       Date:  1968-03       Impact factor: 4.030

Review 8.  Narcotic antagonists.

Authors:  S Archer; L S Harris
Journal:  Fortschr Arzneimittelforsch       Date:  1965

9.  The analgesic effect of opiate-opiate antagonist combinations in the rat.

Authors:  L Grumbach; H I Chernov
Journal:  J Pharmacol Exp Ther       Date:  1965-09       Impact factor: 4.030

10.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03
View more
  14 in total

1.  [D-Pen2, D-Pen5]enkephalin, the standard delta opioid agonist, induces morphine-like behaviors in mice.

Authors:  C W Murray; A Cowan
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

2.  Oxycodone physical dependence and its oral self-administration in C57BL/6J mice.

Authors:  Rachel M Enga; Asti Jackson; M Imad Damaj; Patrick M Beardsley
Journal:  Eur J Pharmacol       Date:  2016-07-05       Impact factor: 4.432

Review 3.  The behavioral pharmacology of hallucinogens.

Authors:  William E Fantegrossi; Kevin S Murnane; Chad J Reissig
Journal:  Biochem Pharmacol       Date:  2007-07-20       Impact factor: 5.858

4.  P-glycoprotein is a major determinant of norbuprenorphine brain exposure and antinociception.

Authors:  Sarah M Brown; Scott D Campbell; Amanda Crafford; Karen J Regina; Michael J Holtzman; Evan D Kharasch
Journal:  J Pharmacol Exp Ther       Date:  2012-06-27       Impact factor: 4.030

5.  Two mechanisms for the meperidine block of action potential production in frog's skeletal muscle; non-specific and opiate drug receptor mediated blockade.

Authors:  G B Frank
Journal:  J Physiol       Date:  1975-11       Impact factor: 5.182

6.  Methodological Considerations for Optimizing and Validating Behavioral Assays.

Authors:  Stacey J Sukoff Rizzo; Jill L Silverman
Journal:  Curr Protoc Mouse Biol       Date:  2016-12-01

7.  Tramadol and another atypical opioid meperidine have exaggerated serotonin syndrome behavioural effects, but decreased analgesic effects, in genetically deficient serotonin transporter (SERT) mice.

Authors:  Meredith A Fox; Catherine L Jensen; Dennis L Murphy
Journal:  Int J Neuropsychopharmacol       Date:  2009-03-11       Impact factor: 5.176

8.  Antagonism of opiate mydriasis in mice.

Authors:  A D Korczyn; M Rock
Journal:  Br J Pharmacol       Date:  1981-08       Impact factor: 8.739

Review 9.  Abuse liability, behavioral pharmacology, and physical-dependence potential of opioids in humans and laboratory animals: lessons from tramadol.

Authors:  David H Epstein; Kenzie L Preston; Donald R Jasinski
Journal:  Biol Psychol       Date:  2006-02-23       Impact factor: 3.251

10.  Straub tail reaction in mice treated with σ(1) receptor antagonist in combination with methamphetamine.

Authors:  Junichi Kitanaka; Nobue Kitanaka; F Scott Hall; George R Uhl; Koh-Ichi Tanaka; Nobuyoshi Nishiyama; Motohiko Takemura
Journal:  Brain Res       Date:  2012-09-08       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.